Anti-ACE2 antibodies that inhibit the anti-inflammatory and anti-fibrotic effects of ACE2 have been described in connective tissue diseases with constrictive vasculopathies, such as SSc, SLE and mixed connective tissue disease (MCTD) (51, 52). This evidence concerns the gene ACE2 and mixed connective tissue disease.